BSE: PPLPHARMA - Piramal Pharma Limited
Yield per half year: +60.75%
Dividend yield: +0.07%
Sector: Healthcare
Reporting Piramal Pharma Limited
Share
IFRS
Annual
Quarterly
| 2022 | 2023 | 2024 | LTM | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|
| EPS | -0.6487 | |||||
| Цена акции ао | 114.75 | 138.8 | 254.55 | 254.55 |
Efficiency
IFRS
Annual
| 2023 | 2024 | 2025 | LTM | Industry average | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|---|
| ROS, % | 0 | 0 | 0 | 0 | -86.65 | ||
| ROCE, % | 0 | 0 | -23.18 | ||||
| Ebit margin, % | 0 | 0 | |||||
| Рентаб EBITDA, % | 0 | 0 | -32.02 | ||||
| Operation Margin, % | 0 | 0 | 0 | 0 | -90.90 |
Coefficients
IFRS
Annual
Dividends
IFRS
Annual
| 2024 | LTM | Industry average | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|
|
Дивиденд
|
0.0013 | 0.0013 | |||
|
Див доход, ао, %
|
0.0704 | 0.0704 | 0.36 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
